Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791568 · ClinicalTrials.gov registry record
Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 121
- Enrollment target
NCT02791568: Completed study, sponsored by University of Wisconsin, Madison.
NCT02791568 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 121 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02791568 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
The purpose of the study is to develop advanced ultrasound (U/S) and Magnetic Resonance Imaging, known as MRI to study uteroplacental health. The goal of this study is to evaluate the blood and oxygen flow to the placenta using advanced U/S and MRI testing.
Primary Outcome
The goal of this research is to develop an arsenal of advanced U/S and MRI techniques that are compatible to be run simultaneously or sequentially to probe uteroplacental health and overcome the limitations posed by obesity and motion.The ideal combination of imaging procedures will help to progress with further human studies that actually benefit clinical diagnosis.
Interventions
- DRUG Ferumoxytol
- PROCEDURE MRI Scan
- PROCEDURE Ultrasound Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2020-07-31 |
What the finished NCT02791568 record still lists
NCT02791568 is an observational study that tracks outcomes without assigning an intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Ferumoxytol is the first listed.
NCT02791568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02791568 about?
NCT02791568 is a clinical study titled "Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation". The purpose of the study is to develop advanced ultrasound (U/S) and Magnetic Resonance Imaging, known as MRI to study uteroplacental health. The goal of this study is to evaluate the blood and oxygen flow to the placenta using advanced U/S and MRI testing.
What is the current status of trial NCT02791568?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2017-01-31. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT02791568?
The interventions under investigation include: Ferumoxytol (DRUG), MRI Scan (PROCEDURE), Ultrasound Scan (PROCEDURE).
Who is sponsoring clinical trial NCT02791568?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI